| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 5.09e-08 | 3 | 75 | 3 | GO:0005220 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 5.40e-07 | 18 | 75 | 4 | GO:0015278 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 5.35e-06 | 31 | 75 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 6.92e-06 | 33 | 75 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 1.80e-05 | 14 | 75 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF18A IQCA1L MYH9 MYO7A ENTPD1 RSF1 MYO18A CDC6 HSP90AA5P HSP90AB3P | 9.63e-05 | 614 | 75 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.46e-04 | 441 | 75 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | ADP binding | 7.80e-04 | 48 | 75 | 3 | GO:0043531 | |
| GeneOntologyMolecularFunction | phospholipase activity | 8.96e-04 | 114 | 75 | 4 | GO:0004620 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.02e-03 | 118 | 75 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 1.30e-03 | 126 | 75 | 4 | GO:0051082 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.42e-03 | 129 | 75 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | lipase activity | 1.82e-03 | 138 | 75 | 4 | GO:0016298 | |
| GeneOntologyMolecularFunction | long-chain fatty acyl-CoA hydrolase activity | 1.83e-03 | 17 | 75 | 2 | GO:0052816 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.91e-03 | 140 | 75 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF18A IQCA1L ARL5B ENTPD1 RSF1 MYO18A CDC6 HSP90AA5P HSP90AB3P | 2.43e-03 | 775 | 75 | 9 | GO:0017111 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.52e-03 | 151 | 75 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 3.06e-03 | 22 | 75 | 2 | GO:0051010 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | 3.18e-03 | 807 | 75 | 9 | GO:0016788 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF18A IQCA1L ARL5B ENTPD1 RSF1 MYO18A CDC6 HSP90AA5P HSP90AB3P | 4.10e-03 | 839 | 75 | 9 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF18A IQCA1L ARL5B ENTPD1 RSF1 MYO18A CDC6 HSP90AA5P HSP90AB3P | 4.14e-03 | 840 | 75 | 9 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF18A IQCA1L ARL5B ENTPD1 RSF1 MYO18A CDC6 HSP90AA5P HSP90AB3P | 4.14e-03 | 840 | 75 | 9 | GO:0016818 |
| GeneOntologyMolecularFunction | fatty acyl-CoA hydrolase activity | 4.60e-03 | 27 | 75 | 2 | GO:0047617 | |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate phosphatase activity | 4.60e-03 | 27 | 75 | 2 | GO:0034593 | |
| GeneOntologyMolecularFunction | acyl-CoA hydrolase activity | 4.94e-03 | 28 | 75 | 2 | GO:0016289 | |
| GeneOntologyMolecularFunction | lysophospholipase activity | 5.29e-03 | 29 | 75 | 2 | GO:0004622 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate phosphatase activity | 5.66e-03 | 30 | 75 | 2 | GO:0052866 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 6.03e-03 | 193 | 75 | 4 | GO:0015276 | |
| GeneOntologyMolecularFunction | nucleocytoplasmic carrier activity | 6.42e-03 | 32 | 75 | 2 | GO:0140142 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 6.47e-03 | 197 | 75 | 4 | GO:0022834 | |
| GeneOntologyMolecularFunction | alcohol binding | 6.70e-03 | 102 | 75 | 3 | GO:0043178 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 4.13e-06 | 9 | 78 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 8.07e-06 | 11 | 78 | 3 | GO:0031094 | |
| Domain | InsP3_rcpt-bd | 5.04e-08 | 3 | 70 | 3 | IPR000493 | |
| Domain | RIH_assoc | 1.00e-06 | 6 | 70 | 3 | PF08454 | |
| Domain | RIH_assoc-dom | 1.00e-06 | 6 | 70 | 3 | IPR013662 | |
| Domain | RIH_dom | 1.00e-06 | 6 | 70 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.00e-06 | 6 | 70 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.00e-06 | 6 | 70 | 3 | IPR015925 | |
| Domain | - | 1.00e-06 | 6 | 70 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.00e-06 | 6 | 70 | 3 | PF01365 | |
| Domain | Ins145_P3_rec | 1.00e-06 | 6 | 70 | 3 | PF08709 | |
| Domain | MIR | 5.94e-06 | 10 | 70 | 3 | PS50919 | |
| Domain | MIR | 5.94e-06 | 10 | 70 | 3 | PF02815 | |
| Domain | MIR | 5.94e-06 | 10 | 70 | 3 | SM00472 | |
| Domain | MIR_motif | 5.94e-06 | 10 | 70 | 3 | IPR016093 | |
| Domain | Teashirt_fam | 4.14e-05 | 3 | 70 | 2 | IPR027008 | |
| Domain | Myosin_head_motor_dom | 3.87e-04 | 38 | 70 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 3.87e-04 | 38 | 70 | 3 | PS51456 | |
| Domain | Myosin_head | 3.87e-04 | 38 | 70 | 3 | PF00063 | |
| Domain | MYSc | 3.87e-04 | 38 | 70 | 3 | SM00242 | |
| Domain | ARM-type_fold | 1.69e-03 | 339 | 70 | 6 | IPR016024 | |
| Domain | Myosin_tail_1 | 2.04e-03 | 18 | 70 | 2 | PF01576 | |
| Domain | Myosin_tail | 2.04e-03 | 18 | 70 | 2 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 2.27e-03 | 19 | 70 | 2 | IPR027401 | |
| Domain | - | 2.27e-03 | 19 | 70 | 2 | 4.10.270.10 | |
| Domain | IQ | 2.40e-03 | 71 | 70 | 3 | PF00612 | |
| Domain | IQ | 3.49e-03 | 81 | 70 | 3 | SM00015 | |
| Domain | - | 3.93e-03 | 25 | 70 | 2 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 3.93e-03 | 25 | 70 | 2 | IPR017946 | |
| Domain | IQ_motif_EF-hand-BS | 4.69e-03 | 90 | 70 | 3 | IPR000048 | |
| Domain | IQ | 5.14e-03 | 93 | 70 | 3 | PS50096 | |
| Domain | MFS | 7.77e-03 | 108 | 70 | 3 | PS50850 | |
| Domain | MFS_sugar_transport-like | 8.03e-03 | 36 | 70 | 2 | IPR005828 | |
| Domain | Sugar_tr | 8.03e-03 | 36 | 70 | 2 | PF00083 | |
| Domain | Ank_2 | 8.66e-03 | 215 | 70 | 4 | PF12796 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 4.99e-07 | 5 | 53 | 3 | M49000 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 9.96e-07 | 6 | 53 | 3 | M47960 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 4.15e-06 | 9 | 53 | 3 | M47852 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 5.91e-06 | 10 | 53 | 3 | M47661 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 8.11e-06 | 11 | 53 | 3 | M49033 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 8.11e-06 | 11 | 53 | 3 | M27466 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 9.35e-06 | 76 | 53 | 5 | M9052 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.40e-05 | 13 | 53 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 1.40e-05 | 13 | 53 | 3 | M47751 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.40e-05 | 13 | 53 | 3 | M47656 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 1.40e-05 | 13 | 53 | 3 | MM14553 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 2.71e-05 | 16 | 53 | 3 | M26945 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 4.66e-05 | 19 | 53 | 3 | M27423 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.66e-05 | 19 | 53 | 3 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 4.66e-05 | 19 | 53 | 3 | M47733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 5.47e-05 | 20 | 53 | 3 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 6.36e-05 | 21 | 53 | 3 | M47689 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 7.35e-05 | 22 | 53 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 7.35e-05 | 22 | 53 | 3 | M47675 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.43e-05 | 23 | 53 | 3 | M47676 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.09e-04 | 25 | 53 | 3 | MM14511 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 1.36e-04 | 70 | 53 | 4 | M8232 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.38e-04 | 27 | 53 | 3 | M12123 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.38e-04 | 27 | 53 | 3 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.54e-04 | 28 | 53 | 3 | M924 | |
| Pathway | WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY | 1.69e-04 | 74 | 53 | 4 | M48080 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.87e-04 | 76 | 53 | 4 | MM15051 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 1.94e-04 | 143 | 53 | 5 | M27107 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 2.30e-04 | 32 | 53 | 3 | MM14983 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 2.51e-04 | 82 | 53 | 4 | M27110 | |
| Pathway | REACTOME_PI_METABOLISM | 2.75e-04 | 84 | 53 | 4 | M676 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 3.01e-04 | 86 | 53 | 4 | M916 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 3.28e-04 | 36 | 53 | 3 | M1315 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 3.28e-04 | 36 | 53 | 3 | M39831 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 4.84e-04 | 41 | 53 | 3 | M512 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 5.19e-04 | 42 | 53 | 3 | M791 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 5.55e-04 | 101 | 53 | 4 | M1979 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 5.96e-04 | 44 | 53 | 3 | M39845 | |
| Pathway | SIG_CHEMOTAXIS | 6.37e-04 | 45 | 53 | 3 | M5193 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 6.80e-04 | 46 | 53 | 3 | M8626 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 8.47e-04 | 113 | 53 | 4 | M16817 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 8.68e-04 | 50 | 53 | 3 | M47951 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 9.04e-04 | 115 | 53 | 4 | M9387 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 1.03e-03 | 53 | 53 | 3 | MM15716 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.09e-03 | 54 | 53 | 3 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.09e-03 | 54 | 53 | 3 | MM15202 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.09e-03 | 54 | 53 | 3 | M26911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 1.15e-03 | 55 | 53 | 3 | M47952 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 1.15e-03 | 211 | 53 | 5 | M649 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 1.35e-03 | 219 | 53 | 5 | M29836 | |
| Pathway | WP_GPR40_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M39526 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.55e-03 | 61 | 53 | 3 | MM15071 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 1.59e-03 | 134 | 53 | 4 | M29840 | |
| Pathway | REACTOME_CA2_PATHWAY | 1.62e-03 | 62 | 53 | 3 | M27321 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 2.30e-03 | 70 | 53 | 3 | M3115 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 2.49e-03 | 72 | 53 | 3 | MM14631 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 2.69e-03 | 74 | 53 | 3 | MM15962 | |
| Pathway | REACTOME_PI_METABOLISM | 3.02e-03 | 77 | 53 | 3 | MM14590 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.05e-03 | 22 | 53 | 2 | MM1370 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 3.13e-03 | 78 | 53 | 3 | M1921 | |
| Pathway | WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE | 3.34e-03 | 23 | 53 | 2 | M39843 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 3.39e-03 | 165 | 53 | 4 | MM15026 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.63e-03 | 24 | 53 | 2 | M13404 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 4.12e-03 | 86 | 53 | 3 | M27206 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 4.12e-03 | 86 | 53 | 3 | M601 | |
| Pathway | KEGG_GAP_JUNCTION | 4.68e-03 | 90 | 53 | 3 | M4013 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 4.68e-03 | 90 | 53 | 3 | M6467 | |
| Pubmed | 2.47e-11 | 4 | 79 | 4 | 10828023 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 10874040 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 9808793 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 20395455 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 17437169 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 18194433 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 18547250 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 36350267 | ||
| Pubmed | IP3 receptors regulate vascular smooth muscle contractility and hypertension. | 1.13e-08 | 3 | 79 | 3 | 27777977 | |
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 11413485 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 26009177 | ||
| Pubmed | Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. | 1.13e-08 | 3 | 79 | 3 | 17581770 | |
| Pubmed | Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. | 1.13e-08 | 3 | 79 | 3 | 18241669 | |
| Pubmed | Receptor-activated single channels in intact human platelets. | 1.13e-08 | 3 | 79 | 3 | 1693919 | |
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 19068129 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 23955339 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 31979185 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 1.13e-08 | 3 | 79 | 3 | 24904548 | |
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 17327232 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 16014380 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 17890015 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. | 1.13e-08 | 3 | 79 | 3 | 23983250 | |
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 1.13e-08 | 3 | 79 | 3 | 9858485 | |
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 20427533 | ||
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 25215520 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B. | 4.50e-08 | 4 | 79 | 3 | 21424589 | |
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 28615414 | ||
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 28419336 | ||
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 11163362 | ||
| Pubmed | IP3R-mediated Ca2+ signaling controls B cell proliferation through metabolic reprogramming. | 4.50e-08 | 4 | 79 | 3 | 35494252 | |
| Pubmed | 1.12e-07 | 5 | 79 | 3 | 7931073 | ||
| Pubmed | InsP₃receptors and Orai channels in pancreatic acinar cells: co-localization and its consequences. | 1.12e-07 | 5 | 79 | 3 | 21568942 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DST MTMR14 RASA3 MYO7A PI4KA INTS11 HECTD4 PLA2G6 NUP214 HECTD1 TNPO3 ARHGEF10L ITPR2 ITPR3 | 1.79e-07 | 1105 | 79 | 14 | 35748872 |
| Pubmed | 2.24e-07 | 6 | 79 | 3 | 23463619 | ||
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 2.24e-07 | 6 | 79 | 3 | 21762810 | |
| Pubmed | 2.24e-07 | 6 | 79 | 3 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 2.24e-07 | 6 | 79 | 3 | 25966694 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 2.24e-07 | 6 | 79 | 3 | 16844763 | |
| Pubmed | 3.92e-07 | 7 | 79 | 3 | 11860456 | ||
| Pubmed | Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. | 3.92e-07 | 7 | 79 | 3 | 22495310 | |
| Pubmed | 9.38e-07 | 9 | 79 | 3 | 25737585 | ||
| Pubmed | Type 1 and 3 inositol trisphosphate receptors are required for extra-embryonic vascular development. | 1.84e-06 | 11 | 79 | 3 | 27514653 | |
| Pubmed | 4.03e-06 | 14 | 79 | 3 | 34630045 | ||
| Pubmed | Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle. | 5.03e-06 | 15 | 79 | 3 | 28578927 | |
| Pubmed | Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin. | 5.09e-06 | 2 | 79 | 2 | 9065779 | |
| Pubmed | Expression of IP3 receptor isoforms at the nodes of Ranvier in rat sciatic nerve. | 5.09e-06 | 2 | 79 | 2 | 17496801 | |
| Pubmed | Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor. | 5.09e-06 | 2 | 79 | 2 | 8663526 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 15890645 | ||
| Pubmed | Mice lacking inositol 1,4,5-trisphosphate receptors exhibit dry eye. | 5.09e-06 | 2 | 79 | 2 | 24901844 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 3906657 | ||
| Pubmed | AIRAP, a new human heat shock gene regulated by heat shock factor 1. | 5.09e-06 | 2 | 79 | 2 | 20185824 | |
| Pubmed | Genomic organization of the mouse T-cell receptor beta-chain gene family. | 5.09e-06 | 2 | 79 | 2 | 3035555 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 33854148 | ||
| Pubmed | Sequence relationships between putative T-cell receptor polypeptides and immunoglobulins. | 5.09e-06 | 2 | 79 | 2 | 6546606 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 6611207 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 18708078 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 15201137 | ||
| Pubmed | Expression and regulation of mouse Mtsh1 during limb and branchial arch development. | 5.09e-06 | 2 | 79 | 2 | 11668608 | |
| Pubmed | The murine T-cell receptor uses a limited repertoire of expressed V beta gene segments. | 5.09e-06 | 2 | 79 | 2 | 2412120 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 19528657 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 8063813 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 3262424 | ||
| Pubmed | Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors. | 5.09e-06 | 2 | 79 | 2 | 8081734 | |
| Pubmed | Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. | 5.09e-06 | 2 | 79 | 2 | 23582047 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 1374893 | ||
| Pubmed | Space exploration by dendritic cells requires maintenance of myosin II activity by IP3 receptor 1. | 5.09e-06 | 2 | 79 | 2 | 25637353 | |
| Pubmed | Predominant use of a V alpha gene segment in mouse T-cell receptors for cytochrome c. | 5.09e-06 | 2 | 79 | 2 | 3025740 | |
| Pubmed | Vertebrate orthologues of the Drosophila region-specific patterning gene teashirt. | 5.09e-06 | 2 | 79 | 2 | 10704881 | |
| Pubmed | IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. | 5.09e-06 | 2 | 79 | 2 | 16195467 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 34297096 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 15632133 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 20813840 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 15713744 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 7559486 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 8805626 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 20843799 | ||
| Pubmed | Type 1 and 2 IP3 receptors respond differently to catecholamines and stress. | 5.09e-06 | 2 | 79 | 2 | 19120126 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 27824130 | ||
| Pubmed | Distinct roles of inositol 1,4,5-trisphosphate receptor types 1 and 3 in Ca2+ signaling. | 5.09e-06 | 2 | 79 | 2 | 14707143 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 6.96e-06 | 202 | 79 | 6 | 33005030 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 7.33e-06 | 440 | 79 | 8 | 34244565 | |
| Pubmed | Rescue of calcineurin Aα(-/-) mice reveals a novel role for the α isoform in the salivary gland. | 1.53e-05 | 3 | 79 | 2 | 21435446 | |
| Pubmed | Teashirt 3 expression in the chick embryo reveals a remarkable association with tendon development. | 1.53e-05 | 3 | 79 | 2 | 16631416 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 2895734 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 22992961 | ||
| Pubmed | Analysis of TSHZ2 and TSHZ3 genes in congenital pelvi-ureteric junction obstruction. | 1.53e-05 | 3 | 79 | 2 | 19745106 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 12032348 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 32320395 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 31540997 | ||
| Pubmed | Restriction fragment length polymorphisms of the mouse T-cell receptor gene families. | 1.53e-05 | 3 | 79 | 2 | 2564371 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 12421829 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 36627348 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 23223241 | ||
| Pubmed | Adenosine A(2A) receptors promote collagen production by a Fli1- and CTGF-mediated mechanism. | 1.53e-05 | 3 | 79 | 2 | 23663495 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 14973285 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 18250332 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 24619424 | ||
| Pubmed | 1.68e-05 | 22 | 79 | 3 | 11696558 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 1.94e-05 | 363 | 79 | 7 | 14691545 | |
| Pubmed | 2.21e-05 | 24 | 79 | 3 | 10843712 | ||
| Interaction | RADX interactions | 1.05e-06 | 49 | 75 | 5 | int:RADX | |
| Interaction | TRPC4 interactions | 1.48e-06 | 23 | 75 | 4 | int:TRPC4 | |
| Interaction | CDKL4 interactions | 1.38e-05 | 13 | 75 | 3 | int:CDKL4 | |
| Interaction | IRAG1 interactions | 1.75e-05 | 14 | 75 | 3 | int:IRAG1 | |
| Interaction | TESPA1 interactions | 2.68e-05 | 16 | 75 | 3 | int:TESPA1 | |
| Interaction | LIMCH1 interactions | 3.57e-05 | 100 | 75 | 5 | int:LIMCH1 | |
| Interaction | CALD1 interactions | 5.82e-05 | 265 | 75 | 7 | int:CALD1 | |
| Interaction | RANBP2 interactions | 5.82e-05 | 361 | 75 | 8 | int:RANBP2 | |
| Interaction | NUP93 interactions | 6.39e-05 | 269 | 75 | 7 | int:NUP93 | |
| Interaction | STIP1 interactions | PPT1 MTMR14 PI4KA SUPT16H CD274 NUP214 TUBGCP2 HECTD1 HSP90AA5P TNPO3 ARHGEF10L PINK1 HSP90AB3P | 7.85e-05 | 1006 | 75 | 13 | int:STIP1 |
| Interaction | CABP2 interactions | 7.86e-05 | 61 | 75 | 4 | int:CABP2 | |
| Interaction | CFL1 interactions | 8.95e-05 | 384 | 75 | 8 | int:CFL1 | |
| Interaction | RASEF interactions | 1.07e-04 | 25 | 75 | 3 | int:RASEF | |
| Interaction | LRRC31 interactions | 1.16e-04 | 205 | 75 | 6 | int:LRRC31 | |
| Interaction | UHRF1 interactions | 1.25e-04 | 208 | 75 | 6 | int:UHRF1 | |
| Interaction | TRPC2 interactions | 1.36e-04 | 5 | 75 | 2 | int:TRPC2 | |
| Interaction | CSE1L interactions | 1.67e-04 | 314 | 75 | 7 | int:CSE1L | |
| Interaction | BBOX1 interactions | 1.69e-04 | 29 | 75 | 3 | int:BBOX1 | |
| Interaction | TRPC1 interactions | 1.69e-04 | 29 | 75 | 3 | int:TRPC1 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 1.65e-08 | 3 | 47 | 3 | 297 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 6.80e-04 | 15 | 47 | 2 | 529 | |
| GeneFamily | Parkinson disease associated genes | 7.75e-04 | 16 | 47 | 2 | 672 | |
| GeneFamily | T cell receptor beta locus at 7q34 | 1.50e-03 | 87 | 47 | 3 | 372 | |
| GeneFamily | Phospholipases | 5.33e-03 | 42 | 47 | 2 | 467 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.41e-05 | 175 | 78 | 5 | 37c2d4e0b6e9a3171931797ce9a54f3347288e57 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.84e-05 | 185 | 78 | 5 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.89e-05 | 186 | 78 | 5 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.04e-05 | 189 | 78 | 5 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.32e-05 | 194 | 78 | 5 | b829a63b51b92507a53ffd0393bd9458b2b9440f | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 2.37e-05 | 195 | 78 | 5 | 1992a1673b7213e25f3c76ac77da35c57daceddd | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.61e-05 | 199 | 78 | 5 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 2.61e-05 | 199 | 78 | 5 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 2.68e-05 | 200 | 78 | 5 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Trm_Tgd|lymph-node_spleen / Manually curated celltypes from each tissue | 1.59e-04 | 155 | 78 | 4 | b0e456c4915076e1d38282e116a6eb3230ae80dc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 162 | 78 | 4 | 68c40d12689cc1b6c797e6e48173f0110f8144e4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 162 | 78 | 4 | 735fa3f77b31a4189e431d05c326403c18cbbffb | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-04 | 164 | 78 | 4 | 1642a67c66eeb77a218e7814e3cfe517d9822955 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-04 | 164 | 78 | 4 | 25758fb8112baf296264122d5d4121f1ebb3d0fa | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 165 | 78 | 4 | e32697321cef424c2ad4e11ee9da3e510d5ce505 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 165 | 78 | 4 | 0fbdd043e11aa8dbff4cd3a4da1b2feb49878a09 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 2.21e-04 | 169 | 78 | 4 | 241644823e6f949aaf4c671d4579721d7ef6b0e5 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.26e-04 | 170 | 78 | 4 | af8b56555cbd5a1016ab9ec2ce88225c58c89648 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.36e-04 | 172 | 78 | 4 | 9a1743abcd5fbd38253ea84d88ad716cfb71de36 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.41e-04 | 173 | 78 | 4 | 5c55e1e27e9e3e77600d378cc87b51cc73907527 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-04 | 174 | 78 | 4 | 0fccd90ef72ec2e5eb369fe6d6d126c60886485a | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-04 | 180 | 78 | 4 | ca2a35bfb67347e47f511589a3d0f763e6664634 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-04 | 180 | 78 | 4 | 4e9e8cde2919610c4ac0025b1c9819808048bc1d | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 180 | 78 | 4 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-04 | 180 | 78 | 4 | 466381bf93c3da6a2a241daadb68e9aad2964eae | |
| ToppCell | Healthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.87e-04 | 181 | 78 | 4 | ac1ee313910c05b1b3cb497bae14565464919c21 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 181 | 78 | 4 | d90faa6115b408c9fbca61fc90ff951e070754ba | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.93e-04 | 182 | 78 | 4 | 37547b36264090b49a193a8ef3a8d88e647f0b79 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.99e-04 | 183 | 78 | 4 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 183 | 78 | 4 | b153425ab0df1e5fa9b953e1f6d4e8e3dc6621b0 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.99e-04 | 183 | 78 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 183 | 78 | 4 | 19e7be1cfdd111bfb840532a6f7c780345dffccf | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.99e-04 | 183 | 78 | 4 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-04 | 183 | 78 | 4 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.99e-04 | 183 | 78 | 4 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.05e-04 | 184 | 78 | 4 | 6e17c8151d6dc543de16d804db956c63c3fda414 | |
| ToppCell | (4)_Endothelial_cells-(40)_EC-arterial|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.05e-04 | 184 | 78 | 4 | 7e1a2971321ddcfa00d78d3e3ba7960e532f9392 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-04 | 184 | 78 | 4 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-MEC-MEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.11e-04 | 185 | 78 | 4 | 76304829fcfb5934188933ca20d33bc8c8b0dc91 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-04 | 185 | 78 | 4 | fa94c4a1660967f211ba095606cd0aa37d38e17a | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-MEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.11e-04 | 185 | 78 | 4 | 0595e7ab37eed690f6e3d16a9a4e9a4bce2b89db | |
| ToppCell | Control-T_cells-NK_cells|Control / group, cell type (main and fine annotations) | 3.11e-04 | 185 | 78 | 4 | 755c0998c729f462399f1d5e88adf4bfae31be30 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.11e-04 | 185 | 78 | 4 | 5a0340c25196453f19e424d346efbf66d2c53ac3 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-04 | 186 | 78 | 4 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-04 | 186 | 78 | 4 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.18e-04 | 186 | 78 | 4 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-04 | 186 | 78 | 4 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.24e-04 | 187 | 78 | 4 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-04 | 187 | 78 | 4 | df0279b7e94e26f5541b0e2a0ce56befa96ec8ca | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.24e-04 | 187 | 78 | 4 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.31e-04 | 188 | 78 | 4 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-04 | 188 | 78 | 4 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 188 | 78 | 4 | 5e13725136114e42d3b59647cf25e0f3c53abb54 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 3.38e-04 | 189 | 78 | 4 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-04 | 190 | 78 | 4 | 92456f6f7eced6e4c4371f495254a65d061c8d0b | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.44e-04 | 190 | 78 | 4 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.44e-04 | 190 | 78 | 4 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-04 | 191 | 78 | 4 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-04 | 192 | 78 | 4 | a94f47a664a3c9d1b0250269674453309ab4bf95 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.58e-04 | 192 | 78 | 4 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-04 | 192 | 78 | 4 | c47df468cf78a90929913c9022e8078a53cdf680 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.58e-04 | 192 | 78 | 4 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-04 | 192 | 78 | 4 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 3.65e-04 | 193 | 78 | 4 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 3.65e-04 | 193 | 78 | 4 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | droplet-Bladder-BLADDER-1m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-04 | 193 | 78 | 4 | 88cd7d0d0da5c776b49fc131f746fe5ad9676fb7 | |
| ToppCell | 10x5'-GI_small-bowel|World / Manually curated celltypes from each tissue | 3.65e-04 | 193 | 78 | 4 | cd89dfe53a114078f06343049685883c8e26508f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.65e-04 | 193 | 78 | 4 | cf3cbf79ccd34ddcf06ec6194a18a7afd7f91f39 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.65e-04 | 193 | 78 | 4 | f25bdd10ef531b8d8441ea84573078b4b1b0f105 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.73e-04 | 194 | 78 | 4 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.73e-04 | 194 | 78 | 4 | 408597c9aa302a44b112c1d612c21fbb0227a82a | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.73e-04 | 194 | 78 | 4 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.73e-04 | 194 | 78 | 4 | ae6d5cf4c825b29e677296df2c0985431c83b82e | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.73e-04 | 194 | 78 | 4 | 2360b5f995b360419de41612368cab9fb61781a1 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.73e-04 | 194 | 78 | 4 | 903ae11708b0cb24538c6982abd57fe6fa95b8d3 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.73e-04 | 194 | 78 | 4 | 58406502a8cbcc3037f79a1b6a683df408297ae5 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.73e-04 | 194 | 78 | 4 | 663e7e7fe48157e808b4f1a0ea6ad41944e857a2 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-04 | 194 | 78 | 4 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-04 | 195 | 78 | 4 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.80e-04 | 195 | 78 | 4 | 2514c1f23424b5fc664d326d31ffd22bafe74ef8 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-04 | 195 | 78 | 4 | f41a68b7c2621594db8d8952e301eeadc96be26f | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.80e-04 | 195 | 78 | 4 | a838bddeed487154791b69d27a68673783ff63c0 | |
| ToppCell | MatrixFB-Fibroblast-B_(Myofibroblast)|MatrixFB / shred on cell class and cell subclass (v4) | 3.87e-04 | 196 | 78 | 4 | 38ea0eaf42f95c321ca23570d0d7752980cf00f8 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 3.87e-04 | 196 | 78 | 4 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | (3)_Macrophage_MARCOneg|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.95e-04 | 197 | 78 | 4 | b0ee2ce1179b60b4542559acb300a34295277dbc | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.95e-04 | 197 | 78 | 4 | da61afba697ec49ca86e062d35a825280da558ac | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 4.02e-04 | 198 | 78 | 4 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | 367C|World / Donor, Lineage, Cell class and subclass (all cells) | 4.02e-04 | 198 | 78 | 4 | ab3a178f392204e2d90eb5a3b5de7849986b1eaf | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-CD8+_T_naive|Int-URO / Disease, condition lineage and cell class | 4.02e-04 | 198 | 78 | 4 | 8c7d00d8c27fb47954d8ac53eebc4582e92b970c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.02e-04 | 198 | 78 | 4 | 0993d6895c0e4f360998ce35abea4ec3dd13e048 | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.02e-04 | 198 | 78 | 4 | 35499a5231818e3432cf69b5c4a58c02f7771db8 | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.02e-04 | 198 | 78 | 4 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.02e-04 | 198 | 78 | 4 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 4.02e-04 | 198 | 78 | 4 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.10e-04 | 199 | 78 | 4 | f1b370d2869ad29c9d8ff41fdcc486fffa781ee2 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.10e-04 | 199 | 78 | 4 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.10e-04 | 199 | 78 | 4 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.10e-04 | 199 | 78 | 4 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 4.18e-04 | 200 | 78 | 4 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | 4.18e-04 | 200 | 78 | 4 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed | |
| Drug | Selegiline hydrochloride [14611-52-0]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 2.99e-06 | 197 | 72 | 7 | 2826_UP | |
| Drug | adenophostin A | 9.86e-06 | 2 | 72 | 2 | ctd:C085029 | |
| Drug | Isocaffeine | 9.86e-06 | 2 | 72 | 2 | CID000001326 | |
| Drug | adenophostin B | 9.86e-06 | 2 | 72 | 2 | CID000656722 | |
| Drug | benzene 1,2,4-trisphosphate | 9.86e-06 | 2 | 72 | 2 | CID000192376 | |
| Drug | 5-deoxy-5-fluoro-myo-inositol | 2.95e-05 | 3 | 72 | 2 | CID000195110 | |
| Drug | apogossypol | 2.95e-05 | 3 | 72 | 2 | CID000454878 | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 3.47e-05 | 194 | 72 | 6 | 3747_DN | |
| Drug | Cholecalciferol [67-97-0]; Down 200; 10.4uM; PC3; HT_HG-U133A | 3.47e-05 | 194 | 72 | 6 | 6656_DN | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A | 3.47e-05 | 194 | 72 | 6 | 4552_UP | |
| Drug | Naringenine [480-41-1]; Up 200; 14.6uM; PC3; HT_HG-U133A | 3.67e-05 | 196 | 72 | 6 | 4597_UP | |
| Drug | Oxalamine citrate salt [1949-20-8]; Up 200; 9.2uM; PC3; HT_HG-U133A | 3.67e-05 | 196 | 72 | 6 | 6624_UP | |
| Drug | copper(II) sulfate pentahydrate; Down 200; 100uM; ssMCF7; HG-U133A | 3.67e-05 | 196 | 72 | 6 | 500_DN | |
| Drug | Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; PC3; HT_HG-U133A | 3.67e-05 | 196 | 72 | 6 | 2080_UP | |
| Drug | Praziquantel [55268-74-1]; Up 200; 12.8uM; PC3; HT_HG-U133A | 3.78e-05 | 197 | 72 | 6 | 5874_UP | |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A | 3.78e-05 | 197 | 72 | 6 | 3763_DN | |
| Drug | Rauwolscine hydrochloride [6211-32-1]; Down 200; 10.2uM; PC3; HT_HG-U133A | 3.78e-05 | 197 | 72 | 6 | 5800_DN | |
| Drug | NS-398; Up 200; 10uM; PC3; HT_HG-U133A | 3.89e-05 | 198 | 72 | 6 | 6892_UP | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A | 3.89e-05 | 198 | 72 | 6 | 5289_UP | |
| Drug | clozapine; Up 200; 10uM; HL60; HT_HG-U133A | 3.89e-05 | 198 | 72 | 6 | 1170_UP | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A | 3.89e-05 | 198 | 72 | 6 | 4441_DN | |
| Drug | Aztreonam [78110-38-0]; Up 200; 9.2uM; PC3; HT_HG-U133A | 3.89e-05 | 198 | 72 | 6 | 5110_UP | |
| Drug | S(+)-Terguride [37686-84-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 4.11e-05 | 200 | 72 | 6 | 5400_UP | |
| Drug | CHEBI:697555 | 5.89e-05 | 4 | 72 | 2 | CID009578246 | |
| Drug | 4,4'-vinylenedipyridine | 5.89e-05 | 4 | 72 | 2 | CID000083382 | |
| Drug | Demecolcine | TCAF1 ARL5B SLCO4C1 INTS11 HASPIN HECTD4 CD274 TSHZ1 CDC6 NFAT5 ITPR1 | 9.27e-05 | 878 | 72 | 11 | ctd:D003703 |
| Drug | AC1Q7BER | 1.47e-04 | 6 | 72 | 2 | CID000005702 | |
| Drug | 3-F-InsP3 | 2.05e-04 | 7 | 72 | 2 | CID003035756 | |
| Drug | Br2BAPTA | 2.05e-04 | 7 | 72 | 2 | CID003081001 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 2.05e-04 | 7 | 72 | 2 | CID009547999 | |
| Drug | DN-9693 | 2.05e-04 | 7 | 72 | 2 | CID000121868 | |
| Drug | papaverine | 2.40e-04 | 176 | 72 | 5 | CID000004680 | |
| Drug | indoline | 2.55e-04 | 39 | 72 | 3 | CID000010328 | |
| Drug | 9 mM of H | 2.73e-04 | 8 | 72 | 2 | CID000130464 | |
| Drug | basic copper carbonate | 2.73e-04 | 8 | 72 | 2 | CID000025503 | |
| Drug | Ns 004 | 2.73e-04 | 8 | 72 | 2 | CID000162750 | |
| Drug | F2 g | 2.73e-04 | 8 | 72 | 2 | CID006857713 | |
| Drug | AC1L9GJJ | 2.75e-04 | 40 | 72 | 3 | CID000444570 | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 3.33e-04 | 189 | 72 | 5 | 3788_DN | |
| Drug | Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; HL60; HT_HG-U133A | 3.42e-04 | 190 | 72 | 5 | 2465_DN | |
| Drug | (+,-)-Synephrine [94-07-5]; Up 200; 24uM; HL60; HT_HG-U133A | 3.42e-04 | 190 | 72 | 5 | 6156_UP | |
| Drug | gossypolone | 3.50e-04 | 9 | 72 | 2 | CID005478622 | |
| Drug | Rilmenidine hemifumarate [54187-04-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 3.58e-04 | 192 | 72 | 5 | 6512_UP | |
| Drug | Asiaticoside [16830-15-2]; Up 200; 4.2uM; MCF7; HT_HG-U133A | 3.58e-04 | 192 | 72 | 5 | 7004_UP | |
| Drug | UTP-NA | 3.63e-04 | 420 | 72 | 7 | CID000001181 | |
| Drug | $l^{1}-borane | 3.66e-04 | 44 | 72 | 3 | CID006397184 | |
| Drug | Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; PC3; HT_HG-U133A | 3.67e-04 | 193 | 72 | 5 | 3672_DN | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; PC3; HT_HG-U133A | 3.67e-04 | 193 | 72 | 5 | 6730_UP | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HT_HG-U133A | 3.76e-04 | 194 | 72 | 5 | 6660_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; PC3; HT_HG-U133A | 3.76e-04 | 194 | 72 | 5 | 4455_DN | |
| Drug | Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | 3.76e-04 | 194 | 72 | 5 | 4492_DN | |
| Drug | Acetohexamide [968-81-0]; Up 200; 12.4uM; HL60; HT_HG-U133A | 3.85e-04 | 195 | 72 | 5 | 1870_UP | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; PC3; HT_HG-U133A | 3.85e-04 | 195 | 72 | 5 | 3802_DN | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; HL60; HT_HG-U133A | 3.85e-04 | 195 | 72 | 5 | 2470_DN | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 3.85e-04 | 195 | 72 | 5 | 5115_UP | |
| Drug | Dimaprit dihydrochloride [23256-33-9]; Down 200; 17uM; MCF7; HT_HG-U133A | 3.85e-04 | 195 | 72 | 5 | 7480_DN | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; PC3; HT_HG-U133A | 3.85e-04 | 195 | 72 | 5 | 4508_DN | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.85e-04 | 195 | 72 | 5 | 2234_DN | |
| Drug | Clorsulon [60200-06-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.85e-04 | 195 | 72 | 5 | 2884_DN | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; PC3; HT_HG-U133A | 3.85e-04 | 195 | 72 | 5 | 4495_DN | |
| Drug | Idoxuridine [54-42-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 4200_DN | |
| Drug | Clobetasol propionate [25122-46-7]; Down 200; 8.6uM; PC3; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 4497_DN | |
| Drug | SC-560; Up 200; 10uM; PC3; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 6865_UP | |
| Drug | Methacycline hydrochloride [3963-95-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 7321_UP | |
| Drug | Diflorasone Diacetate [33564-31-7]; Down 200; 8uM; MCF7; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 2798_DN | |
| Drug | Ofloxacin [82419-36-1]; Down 200; 11uM; PC3; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 3673_DN | |
| Drug | Ethacrynic acid [58-54-8]; Up 200; 13.2uM; PC3; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 5742_UP | |
| Drug | Lactobionic acid [96-82-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 6605_DN | |
| Drug | 3-Acetamidocoumarin [779-30-6]; Up 200; 19.6uM; HL60; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 2941_UP | |
| Drug | Gliclazide [21187-98-4]; Up 200; 12.4uM; HL60; HG-U133A | 3.94e-04 | 196 | 72 | 5 | 1720_UP | |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; PC3; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 4189_DN | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 1uM; MCF7; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 4382_DN | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 3413_UP | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 2259_DN | |
| Drug | Berberine chloride [633-65-8]; Up 200; 10.8uM; HL60; HG-U133A | 4.03e-04 | 197 | 72 | 5 | 1778_UP | |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Up 200; 8.2uM; HL60; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 2445_UP | |
| Drug | Colistin sulfate [1264-72-8]; Down 200; 3uM; HL60; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 2491_DN | |
| Drug | Citalopram hydrobromide [59729-32-7]; Up 200; 1uM; PC3; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 4555_UP | |
| Drug | Clopamide [636-54-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 5402_UP | |
| Drug | Thyroxine (L) [51-48-9]; Up 200; 5.2uM; PC3; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 4069_UP | |
| Drug | Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 3195_UP | |
| Drug | Methiazole; Up 200; 15uM; PC3; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 4532_UP | |
| Drug | Oxolinic acid [14698-29-4]; Up 200; 15.4uM; PC3; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 2103_UP | |
| Drug | Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; PC3; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 6741_DN | |
| Drug | Fenofibrate [49562-28-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 7474_UP | |
| Drug | Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 4974_DN | |
| Drug | Ribavirin [36791-04-5]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 6018_DN | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 6198_UP | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 4764_DN | |
| Drug | Cefaclor [70356-03-5]; Up 200; 10.4uM; PC3; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 6622_UP | |
| Drug | Quipazine dimaleate salt [4774-24-7]; Down 200; 9uM; MCF7; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 2782_DN | |
| Drug | Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 3247_UP | |
| Drug | Carteolol hydrochloride [51781-21-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 3276_UP | |
| Drug | Articaine hydrochloride [23964-57-0]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 6517_UP | |
| Drug | Lycorine hydrochloride [2188-68-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 3891_UP | |
| Drug | nocodazole; Down 200; 1uM; MCF7; HG-U133A | 4.13e-04 | 198 | 72 | 5 | 621_DN | |
| Drug | Bicuculline (+) [485-49-4]; Down 200; 10.8uM; HL60; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 2139_DN | |
| Drug | Nadolol [42200-33-9]; Up 200; 13uM; MCF7; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 3359_UP | |
| Drug | Cefmetazole sodium salt [56796-39-5]; Up 200; 8.2uM; PC3; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 5868_UP | |
| Drug | Levamisole hydrochloride [16595-80-5]; Up 200; 16.6uM; PC3; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 2094_UP | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 3.15e-06 | 12 | 73 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | Anoxic Encephalopathy | 6.04e-06 | 2 | 73 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 6.04e-06 | 2 | 73 | 2 | C1527348 | |
| Disease | Anoxia of brain | 6.04e-06 | 2 | 73 | 2 | C0995195 | |
| Disease | Hypoxic Brain Damage | 6.04e-06 | 2 | 73 | 2 | C1140716 | |
| Disease | Leber congenital amaurosis (is_implicated_in) | 9.00e-05 | 6 | 73 | 2 | DOID:14791 (is_implicated_in) | |
| Disease | hematocrit | 8.54e-04 | 1011 | 73 | 9 | EFO_0004348 | |
| Disease | Parkinson disease | 1.35e-03 | 22 | 73 | 2 | cv:C0030567 | |
| Disease | thrombocytopenia (is_implicated_in) | 2.04e-03 | 27 | 73 | 2 | DOID:1588 (is_implicated_in) | |
| Disease | Hyalinosis, Segmental Glomerular | 2.19e-03 | 28 | 73 | 2 | C0086432 | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 2.35e-03 | 29 | 73 | 2 | cv:C5779548 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KTCTQKEVMFLGEME | 326 | Q15173 | |
| CKMTQLMKAAKSGTK | 241 | Q9HCE6 | |
| EKDASFKICMKMCLL | 86 | Q8IZ81 | |
| KQDMKGCMTAAEISK | 126 | Q96KC2 | |
| QFCKMMKAKPDIISG | 951 | Q96NH3 | |
| MVDDKEKNMKCLTFF | 1 | Q9Y2F9 | |
| MKMKIQLSEALCGFK | 261 | Q8WW22 | |
| RKSAGSMCITQFMKK | 871 | Q13111 | |
| MMDVKKCGIQDTNSK | 266 | Q9NZQ7 | |
| MSKLEKMQEACGSKS | 741 | Q14644 | |
| GKYVKKCQDMVMTEL | 1321 | Q14571 | |
| GKYVKKCQDMIMTEL | 1311 | Q14573 | |
| TLTDCVAMMSDKAKK | 636 | Q96PE3 | |
| MCVKTSAKEGMALSK | 256 | A6NJZ3 | |
| KFIKKCQDMVMAELV | 1331 | Q14643 | |
| FTSQMIKDCMKKVVA | 121 | Q5TA45 | |
| ICDLMVENKKVKFGM | 211 | Q8NCE2 | |
| LIENPIMKSKMSKFC | 2186 | Q03001 | |
| IMKSKMSKFCGVNET | 2191 | Q03001 | |
| MEESKEKFENLCKLM | 426 | Q58FF7 | |
| MMCSEDKVEKATGKR | 466 | Q8NI77 | |
| LTDVQLMKGKQECMD | 141 | Q00613 | |
| LMKGKQECMDSKLLA | 146 | Q00613 | |
| TKFENLCKIMKDMLE | 251 | Q58FG0 | |
| EKCCVETKMKMLFLA | 546 | Q9BXM7 | |
| EAMLNFCEKETKKLM | 66 | P29536 | |
| TGMAAVKKKSLCIQM | 1011 | Q92614 | |
| EDKAIQKDKSGMMQC | 921 | P42356 | |
| KACFQVGTSEEMKML | 726 | P35658 | |
| CMQKFTQSMKLDGEL | 761 | Q9BSJ2 | |
| KSSVMKKCKAANPEM | 181 | Q7L5L3 | |
| KKCFPKGVDMMAALD | 331 | Q9UI32 | |
| VADMKKKMEDSVGCL | 1366 | P35579 | |
| KVSQEKVTEMMKKFC | 376 | P49961 | |
| CKIMGETFKKLNAME | 941 | Q9Y4D8 | |
| EKVVKMDRDMTKGGC | 1566 | Q9Y4D8 | |
| AMKAMKTTGCNLDKV | 571 | O94916 | |
| EELEVVKGKMMACKH | 131 | B7ZAP0 | |
| VKGKMMACKHCSDIF | 136 | B7ZAP0 | |
| DSFMKTLRSKMGKCC | 51 | A0JP26 | |
| CNPLSMGAIKKMVEK | 46 | P50897 | |
| ISKPFFKLMCMGDIK | 2266 | Q9ULT8 | |
| FKLMCMGDIKSNMSK | 2271 | Q9ULT8 | |
| EVMKKNMMFIKTCAC | 311 | P29279 | |
| EQMKIKSGKCNMAAA | 6 | Q6V1X1 | |
| MKMCALEEEKGKYQL | 96 | Q6ZRK6 | |
| NMDGKELCKMNKEDF | 161 | Q01543 | |
| KELKGFKTIMLNCMS | 221 | Q99741 | |
| DQYMKMTVCLETEKK | 196 | P53004 | |
| MTFKTKCNTPAMKQI | 756 | Q8TF76 | |
| CEAQTVKKMMGSVMK | 36 | Q17RS7 | |
| MQEGIKCMEGLKTSF | 2066 | Q8NDH2 | |
| MTKVEESFQKAMGLK | 6 | Q5VU69 | |
| ACFVQTSPKQEKMKM | 16 | O75715 | |
| MEKKGYLEMSVECKL | 106 | Q96T23 | |
| VCGMETKKDTAQIMF | 176 | Q9Y267 | |
| SDMCKKMFEVEKVNC | 106 | P54317 | |
| MNAVGCLKSEVKMQK | 131 | Q5BJF6 | |
| KQMVSGAKDLVCSKM | 71 | Q96Q06 | |
| AEKDMCLSSSKKGML | 136 | Q7L1I2 | |
| NETMTEKLVKFMKCG | 131 | Q9Y4C2 | |
| VAMKEKCKFGMTSTI | 301 | Q6UWF7 | |
| MGKKMLVKAVCTETG | 571 | A6NCM1 | |
| EECILQKDGMVQKMS | 71 | Q8N165 | |
| LCIDKEKCMGMRKTF | 461 | Q96M29 | |
| KFSQKGCAEMIISMD | 261 | O60733 | |
| MVFCDDKIIFMASKK | 66 | Q9Y5B9 | |
| QLTDMEKCILKYMKG | 176 | Q9NUQ7 | |
| SKEGCKKKEMLQMVC | 101 | Q8N6M9 | |
| GDQEKMAKCKRFLMS | 416 | Q8WUH2 | |
| MKAMQSLKSRGCVKE | 46 | Q9NQ39 | |
| FMKKTIDMLQIEFKC | 151 | P23942 | |
| FLVSKFRMTCKNTMK | 441 | Q6ZQN7 | |
| VMGMTNKKSLKCEQH | 31 | A0A577 | |
| MDKEDAQKVLKCMFC | 266 | Q9NRE2 | |
| KSKMGFQEMVEIKDS | 931 | Q4KWH8 | |
| TKTCKQVVVSEYMKM | 171 | Q8N9V2 | |
| TCVEKAGTDEKMLMK | 186 | Q9Y5L0 | |
| VMGMTNKKSLKCEQH | 31 | A0A589 | |
| GKTKCMMKSSDCVIK | 71 | Q9Y3S2 | |
| HSVDISSKCMMKKFS | 61 | A6NHJ4 | |
| VMGMTNKKSLKCEQH | 31 | A0A539 | |
| EMEGKEDAQKVLKCM | 296 | Q6ZSZ6 | |
| YCMLEGMSEDQKKKL | 256 | Q13402 |